Medical Care
Global Preimplantation Genetics Diagnosis (PGD) Market Research Report 2024
- Mar 12, 24
- ID: 114424
- Pages: 83
- Figures: 170
- Views: 17
The global Preimplantation Genetics Diagnosis (PGD) market was valued at US$ 97 million in 2023 and is anticipated to reach US$ 127.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
North American market for Preimplantation Genetics Diagnosis (PGD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preimplantation Genetics Diagnosis (PGD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Preimplantation Genetics Diagnosis (PGD) in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Preimplantation Genetics Diagnosis (PGD) include Abbott Laboratories, Natera, Inc, PerkinElmer, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Agilent Technologies and Quest Diagnostics Incorporated, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetics Diagnosis (PGD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetics Diagnosis (PGD).
Report Scope
The Preimplantation Genetics Diagnosis (PGD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preimplantation Genetics Diagnosis (PGD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preimplantation Genetics Diagnosis (PGD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Natera, Inc
PerkinElmer
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
Laboratory Corporation of America Holdings
Agilent Technologies
Quest Diagnostics Incorporated
Cooper Surgical
Beijing Genomics Institute (BGI)
Genea Limited
Segment by Type
Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
Aneuploidy
X-Linked Diseases
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preimplantation Genetics Diagnosis (PGD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Preimplantation Genetics Diagnosis (PGD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preimplantation Genetics Diagnosis (PGD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Preimplantation Genetics Diagnosis (PGD) in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Preimplantation Genetics Diagnosis (PGD) include Abbott Laboratories, Natera, Inc, PerkinElmer, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Agilent Technologies and Quest Diagnostics Incorporated, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetics Diagnosis (PGD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetics Diagnosis (PGD).
Report Scope
The Preimplantation Genetics Diagnosis (PGD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preimplantation Genetics Diagnosis (PGD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preimplantation Genetics Diagnosis (PGD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Natera, Inc
PerkinElmer
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
Laboratory Corporation of America Holdings
Agilent Technologies
Quest Diagnostics Incorporated
Cooper Surgical
Beijing Genomics Institute (BGI)
Genea Limited
Segment by Type
Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
Aneuploidy
X-Linked Diseases
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preimplantation Genetics Diagnosis (PGD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Gender Selection
1.2.3 Chromosomal Abnormalities
1.2.4 Single Gene Disorders
1.2.5 HLA Typing
1.2.6 Aneuploidy
1.2.7 X-Linked Diseases
1.2.8 Others
1.3 Market by Application
1.3.1 Global Preimplantation Genetics Diagnosis (PGD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Perspective (2019-2030)
2.2 Preimplantation Genetics Diagnosis (PGD) Growth Trends by Region
2.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Region (2019-2024)
2.2.3 Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Region (2025-2030)
2.3 Preimplantation Genetics Diagnosis (PGD) Market Dynamics
2.3.1 Preimplantation Genetics Diagnosis (PGD) Industry Trends
2.3.2 Preimplantation Genetics Diagnosis (PGD) Market Drivers
2.3.3 Preimplantation Genetics Diagnosis (PGD) Market Challenges
2.3.4 Preimplantation Genetics Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue
3.1.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue (2019-2024)
3.1.2 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Players (2019-2024)
3.2 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetics Diagnosis (PGD) Revenue
3.4 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetics Diagnosis (PGD) Revenue in 2023
3.5 Preimplantation Genetics Diagnosis (PGD) Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
3.7 Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Type
4.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Type (2019-2024)
4.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2025-2030)
5 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Application
5.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Application (2019-2024)
5.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size (2019-2030)
6.2 North America Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024)
6.4 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size (2019-2030)
7.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024)
7.4 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size (2019-2030)
8.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size (2019-2030)
9.2 Latin America Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024)
9.4 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size (2019-2030)
10.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Introduction
11.1.4 Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Natera, Inc
11.2.1 Natera, Inc Company Detail
11.2.2 Natera, Inc Business Overview
11.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Introduction
11.2.4 Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.2.5 Natera, Inc Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Detail
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Introduction
11.3.4 PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.3.5 PerkinElmer Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Introduction
11.4.4 Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.4.5 Illumina Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Introduction
11.6.4 Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Laboratory Corporation of America Holdings
11.7.1 Laboratory Corporation of America Holdings Company Detail
11.7.2 Laboratory Corporation of America Holdings Business Overview
11.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Introduction
11.7.4 Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.7.5 Laboratory Corporation of America Holdings Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Introduction
11.8.4 Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.8.5 Agilent Technologies Recent Development
11.9 Quest Diagnostics Incorporated
11.9.1 Quest Diagnostics Incorporated Company Detail
11.9.2 Quest Diagnostics Incorporated Business Overview
11.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Introduction
11.9.4 Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.9.5 Quest Diagnostics Incorporated Recent Development
11.10 Cooper Surgical
11.10.1 Cooper Surgical Company Detail
11.10.2 Cooper Surgical Business Overview
11.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Introduction
11.10.4 Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.10.5 Cooper Surgical Recent Development
11.11 Beijing Genomics Institute (BGI)
11.11.1 Beijing Genomics Institute (BGI) Company Detail
11.11.2 Beijing Genomics Institute (BGI) Business Overview
11.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Introduction
11.11.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.11.5 Beijing Genomics Institute (BGI) Recent Development
11.12 Genea Limited
11.12.1 Genea Limited Company Detail
11.12.2 Genea Limited Business Overview
11.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Introduction
11.12.4 Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.12.5 Genea Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Gender Selection
1.2.3 Chromosomal Abnormalities
1.2.4 Single Gene Disorders
1.2.5 HLA Typing
1.2.6 Aneuploidy
1.2.7 X-Linked Diseases
1.2.8 Others
1.3 Market by Application
1.3.1 Global Preimplantation Genetics Diagnosis (PGD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Perspective (2019-2030)
2.2 Preimplantation Genetics Diagnosis (PGD) Growth Trends by Region
2.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Region (2019-2024)
2.2.3 Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Region (2025-2030)
2.3 Preimplantation Genetics Diagnosis (PGD) Market Dynamics
2.3.1 Preimplantation Genetics Diagnosis (PGD) Industry Trends
2.3.2 Preimplantation Genetics Diagnosis (PGD) Market Drivers
2.3.3 Preimplantation Genetics Diagnosis (PGD) Market Challenges
2.3.4 Preimplantation Genetics Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue
3.1.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue (2019-2024)
3.1.2 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Players (2019-2024)
3.2 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetics Diagnosis (PGD) Revenue
3.4 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetics Diagnosis (PGD) Revenue in 2023
3.5 Preimplantation Genetics Diagnosis (PGD) Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
3.7 Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Type
4.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Type (2019-2024)
4.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2025-2030)
5 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Application
5.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Application (2019-2024)
5.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size (2019-2030)
6.2 North America Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024)
6.4 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size (2019-2030)
7.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024)
7.4 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size (2019-2030)
8.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size (2019-2030)
9.2 Latin America Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024)
9.4 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size (2019-2030)
10.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Introduction
11.1.4 Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Natera, Inc
11.2.1 Natera, Inc Company Detail
11.2.2 Natera, Inc Business Overview
11.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Introduction
11.2.4 Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.2.5 Natera, Inc Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Detail
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Introduction
11.3.4 PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.3.5 PerkinElmer Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Introduction
11.4.4 Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.4.5 Illumina Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Introduction
11.6.4 Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Laboratory Corporation of America Holdings
11.7.1 Laboratory Corporation of America Holdings Company Detail
11.7.2 Laboratory Corporation of America Holdings Business Overview
11.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Introduction
11.7.4 Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.7.5 Laboratory Corporation of America Holdings Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Introduction
11.8.4 Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.8.5 Agilent Technologies Recent Development
11.9 Quest Diagnostics Incorporated
11.9.1 Quest Diagnostics Incorporated Company Detail
11.9.2 Quest Diagnostics Incorporated Business Overview
11.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Introduction
11.9.4 Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.9.5 Quest Diagnostics Incorporated Recent Development
11.10 Cooper Surgical
11.10.1 Cooper Surgical Company Detail
11.10.2 Cooper Surgical Business Overview
11.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Introduction
11.10.4 Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.10.5 Cooper Surgical Recent Development
11.11 Beijing Genomics Institute (BGI)
11.11.1 Beijing Genomics Institute (BGI) Company Detail
11.11.2 Beijing Genomics Institute (BGI) Business Overview
11.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Introduction
11.11.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.11.5 Beijing Genomics Institute (BGI) Recent Development
11.12 Genea Limited
11.12.1 Genea Limited Company Detail
11.12.2 Genea Limited Business Overview
11.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Introduction
11.12.4 Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
11.12.5 Genea Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Gender Selection
Table 3. Key Players of Chromosomal Abnormalities
Table 4. Key Players of Single Gene Disorders
Table 5. Key Players of HLA Typing
Table 6. Key Players of Aneuploidy
Table 7. Key Players of X-Linked Diseases
Table 8. Key Players of Others
Table 9. Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region (2019-2024)
Table 13. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region (2025-2030)
Table 15. Preimplantation Genetics Diagnosis (PGD) Market Trends
Table 16. Preimplantation Genetics Diagnosis (PGD) Market Drivers
Table 17. Preimplantation Genetics Diagnosis (PGD) Market Challenges
Table 18. Preimplantation Genetics Diagnosis (PGD) Market Restraints
Table 19. Global Preimplantation Genetics Diagnosis (PGD) Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Players (2019-2024)
Table 21. Global Top Preimplantation Genetics Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2023)
Table 22. Ranking of Global Top Preimplantation Genetics Diagnosis (PGD) Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Preimplantation Genetics Diagnosis (PGD) Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
Table 26. Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2019-2024)
Table 30. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2025-2030)
Table 32. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2019-2024)
Table 34. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2025-2030)
Table 36. North America Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 51. Abbott Laboratories Company Detail
Table 52. Abbott Laboratories Business Overview
Table 53. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product
Table 54. Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 55. Abbott Laboratories Recent Development
Table 56. Natera, Inc Company Detail
Table 57. Natera, Inc Business Overview
Table 58. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Product
Table 59. Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 60. Natera, Inc Recent Development
Table 61. PerkinElmer Company Detail
Table 62. PerkinElmer Business Overview
Table 63. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product
Table 64. PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 65. PerkinElmer Recent Development
Table 66. Illumina Company Detail
Table 67. Illumina Business Overview
Table 68. Illumina Preimplantation Genetics Diagnosis (PGD) Product
Table 69. Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 70. Illumina Recent Development
Table 71. F. Hoffmann-La Roche Company Detail
Table 72. F. Hoffmann-La Roche Business Overview
Table 73. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product
Table 74. F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 75. F. Hoffmann-La Roche Recent Development
Table 76. Thermo Fisher Scientific Company Detail
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product
Table 79. Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Laboratory Corporation of America Holdings Company Detail
Table 82. Laboratory Corporation of America Holdings Business Overview
Table 83. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product
Table 84. Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 85. Laboratory Corporation of America Holdings Recent Development
Table 86. Agilent Technologies Company Detail
Table 87. Agilent Technologies Business Overview
Table 88. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product
Table 89. Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 90. Agilent Technologies Recent Development
Table 91. Quest Diagnostics Incorporated Company Detail
Table 92. Quest Diagnostics Incorporated Business Overview
Table 93. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product
Table 94. Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 95. Quest Diagnostics Incorporated Recent Development
Table 96. Cooper Surgical Company Detail
Table 97. Cooper Surgical Business Overview
Table 98. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product
Table 99. Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 100. Cooper Surgical Recent Development
Table 101. Beijing Genomics Institute (BGI) Company Detail
Table 102. Beijing Genomics Institute (BGI) Business Overview
Table 103. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product
Table 104. Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 105. Beijing Genomics Institute (BGI) Recent Development
Table 106. Genea Limited Company Detail
Table 107. Genea Limited Business Overview
Table 108. Genea Limited Preimplantation Genetics Diagnosis (PGD) Product
Table 109. Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 110. Genea Limited Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetics Diagnosis (PGD) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Type: 2023 VS 2030
Figure 3. Gender Selection Features
Figure 4. Chromosomal Abnormalities Features
Figure 5. Single Gene Disorders Features
Figure 6. HLA Typing Features
Figure 7. Aneuploidy Features
Figure 8. X-Linked Diseases Features
Figure 9. Others Features
Figure 10. Global Preimplantation Genetics Diagnosis (PGD) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Application: 2023 VS 2030
Figure 12. Hospitals Case Studies
Figure 13. Clinics Case Studies
Figure 14. Others Case Studies
Figure 15. Preimplantation Genetics Diagnosis (PGD) Report Years Considered
Figure 16. Global Preimplantation Genetics Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Preimplantation Genetics Diagnosis (PGD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region: 2023 VS 2030
Figure 19. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Players in 2023
Figure 20. Global Top Preimplantation Genetics Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Preimplantation Genetics Diagnosis (PGD) Revenue in 2023
Figure 22. North America Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 24. United States Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 28. Germany Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Share by Region (2019-2030)
Figure 36. China Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 44. Mexico Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 48. Turkey Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Abbott Laboratories Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 51. Natera, Inc Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 52. PerkinElmer Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 53. Illumina Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 56. Laboratory Corporation of America Holdings Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 57. Agilent Technologies Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 58. Quest Diagnostics Incorporated Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 59. Cooper Surgical Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 60. Beijing Genomics Institute (BGI) Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 61. Genea Limited Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Gender Selection
Table 3. Key Players of Chromosomal Abnormalities
Table 4. Key Players of Single Gene Disorders
Table 5. Key Players of HLA Typing
Table 6. Key Players of Aneuploidy
Table 7. Key Players of X-Linked Diseases
Table 8. Key Players of Others
Table 9. Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region (2019-2024)
Table 13. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region (2025-2030)
Table 15. Preimplantation Genetics Diagnosis (PGD) Market Trends
Table 16. Preimplantation Genetics Diagnosis (PGD) Market Drivers
Table 17. Preimplantation Genetics Diagnosis (PGD) Market Challenges
Table 18. Preimplantation Genetics Diagnosis (PGD) Market Restraints
Table 19. Global Preimplantation Genetics Diagnosis (PGD) Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Players (2019-2024)
Table 21. Global Top Preimplantation Genetics Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2023)
Table 22. Ranking of Global Top Preimplantation Genetics Diagnosis (PGD) Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Preimplantation Genetics Diagnosis (PGD) Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
Table 26. Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2019-2024)
Table 30. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2025-2030)
Table 32. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2019-2024)
Table 34. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2025-2030)
Table 36. North America Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 51. Abbott Laboratories Company Detail
Table 52. Abbott Laboratories Business Overview
Table 53. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product
Table 54. Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 55. Abbott Laboratories Recent Development
Table 56. Natera, Inc Company Detail
Table 57. Natera, Inc Business Overview
Table 58. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Product
Table 59. Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 60. Natera, Inc Recent Development
Table 61. PerkinElmer Company Detail
Table 62. PerkinElmer Business Overview
Table 63. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product
Table 64. PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 65. PerkinElmer Recent Development
Table 66. Illumina Company Detail
Table 67. Illumina Business Overview
Table 68. Illumina Preimplantation Genetics Diagnosis (PGD) Product
Table 69. Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 70. Illumina Recent Development
Table 71. F. Hoffmann-La Roche Company Detail
Table 72. F. Hoffmann-La Roche Business Overview
Table 73. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product
Table 74. F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 75. F. Hoffmann-La Roche Recent Development
Table 76. Thermo Fisher Scientific Company Detail
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product
Table 79. Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Laboratory Corporation of America Holdings Company Detail
Table 82. Laboratory Corporation of America Holdings Business Overview
Table 83. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product
Table 84. Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 85. Laboratory Corporation of America Holdings Recent Development
Table 86. Agilent Technologies Company Detail
Table 87. Agilent Technologies Business Overview
Table 88. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product
Table 89. Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 90. Agilent Technologies Recent Development
Table 91. Quest Diagnostics Incorporated Company Detail
Table 92. Quest Diagnostics Incorporated Business Overview
Table 93. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product
Table 94. Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 95. Quest Diagnostics Incorporated Recent Development
Table 96. Cooper Surgical Company Detail
Table 97. Cooper Surgical Business Overview
Table 98. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product
Table 99. Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 100. Cooper Surgical Recent Development
Table 101. Beijing Genomics Institute (BGI) Company Detail
Table 102. Beijing Genomics Institute (BGI) Business Overview
Table 103. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product
Table 104. Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 105. Beijing Genomics Institute (BGI) Recent Development
Table 106. Genea Limited Company Detail
Table 107. Genea Limited Business Overview
Table 108. Genea Limited Preimplantation Genetics Diagnosis (PGD) Product
Table 109. Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 110. Genea Limited Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetics Diagnosis (PGD) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Type: 2023 VS 2030
Figure 3. Gender Selection Features
Figure 4. Chromosomal Abnormalities Features
Figure 5. Single Gene Disorders Features
Figure 6. HLA Typing Features
Figure 7. Aneuploidy Features
Figure 8. X-Linked Diseases Features
Figure 9. Others Features
Figure 10. Global Preimplantation Genetics Diagnosis (PGD) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Application: 2023 VS 2030
Figure 12. Hospitals Case Studies
Figure 13. Clinics Case Studies
Figure 14. Others Case Studies
Figure 15. Preimplantation Genetics Diagnosis (PGD) Report Years Considered
Figure 16. Global Preimplantation Genetics Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Preimplantation Genetics Diagnosis (PGD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region: 2023 VS 2030
Figure 19. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Players in 2023
Figure 20. Global Top Preimplantation Genetics Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Preimplantation Genetics Diagnosis (PGD) Revenue in 2023
Figure 22. North America Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 24. United States Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 28. Germany Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Share by Region (2019-2030)
Figure 36. China Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 44. Mexico Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 48. Turkey Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Abbott Laboratories Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 51. Natera, Inc Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 52. PerkinElmer Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 53. Illumina Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 56. Laboratory Corporation of America Holdings Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 57. Agilent Technologies Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 58. Quest Diagnostics Incorporated Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 59. Cooper Surgical Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 60. Beijing Genomics Institute (BGI) Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 61. Genea Limited Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Paint Leveling Agent Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Adhesion Promoters Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Rheological Additives Market Insights, Forecast to 2030
Dec 22, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232